Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital

NEXT STORY
Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of STAT-205 for Acute COVID-19
PREV STORY
AIM ImmunoTech Submits IND and Accompanying Fast Track Application for Phase 2 Trial of Ampligen in Patients with Locally Advanced or Metastatic Late-Stage Pancreatic Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals Announces Initiation of Phase II Trial of CPI-613 in Combination with Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

author_avatar
NASDAQ Market News

TRACON Announces Clinical Data Presentations at Upcoming ASCO Annual Meeting

SAN DIEGO, April 21, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...

author_avatar
NASDAQ Market News

CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News